These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 11205911)

  • 1. Differential effects of adenovirus-p16 on bladder cancer cell lines can be overcome by the addition of butyrate.
    Lee CT; Seol JY; Park KH; Yoo CG; Kim YW; Ahn C; Song YW; Han SK; Han JS; Kim S; Lee JS; Shim YS
    Clin Cancer Res; 2001 Jan; 7(1):210-4. PubMed ID: 11205911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated delivery of p16 to p16-deficient human bladder cancer cells confers chemoresistance to cisplatin and paclitaxel.
    Grim J; D'Amico A; Frizelle S; Zhou J; Kratzke RA; Curiel DT
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2415-23. PubMed ID: 9815642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
    Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A
    Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy.
    Li Y; Pong RC; Bergelson JM; Hall MC; Sagalowsky AI; Tseng CP; Wang Z; Hsieh JT
    Cancer Res; 1999 Jan; 59(2):325-30. PubMed ID: 9927041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus.
    Wolf JK; Kim TE; Fightmaster D; Bodurka D; Gershenson DM; Mills G; Wharton JT
    Gynecol Oncol; 1999 Apr; 73(1):27-34. PubMed ID: 10094876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro efficacy of Fas ligand gene therapy for the treatment of bladder cancer.
    Sudarshan S; Holman DH; Hyer ML; Voelkel-Johnson C; Dong JY; Norris JS
    Cancer Gene Ther; 2005 Jan; 12(1):12-8. PubMed ID: 15514684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta.
    Brüning A; Runnebaum IB
    Gene Ther; 2003 Feb; 10(3):198-205. PubMed ID: 12571626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy.
    Pagliaro LC; Keyhani A; Williams D; Woods D; Liu B; Perrotte P; Slaton JW; Merritt JA; Grossman HB; Dinney CP
    J Clin Oncol; 2003 Jun; 21(12):2247-53. PubMed ID: 12805322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
    Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
    Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.
    Loskog A; Tötterman TH; Böhle A; Brandau S
    Cancer Gene Ther; 2002 Oct; 9(10):846-53. PubMed ID: 12224026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced transgene expression in urothelial cancer gene therapy with histone deacetylase inhibitor.
    Okegawa T; Nutahara K; Pong RC; Higashihara E; Hsieh JT
    J Urol; 2005 Aug; 174(2):747-52. PubMed ID: 16006969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of viral vectors: gene transfer efficiency and tissue specificity in a bladder cancer model.
    Siemens DR; Crist S; Austin JC; Tartaglia J; Ratliff T
    J Urol; 2003 Sep; 170(3):979-84. PubMed ID: 12913754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Construction and study of replication-defective adenovirus targeting hepatocarcinoma].
    Xu DY; Du ZY; Wang Y; Chen HH; Xu YJ; Lu YL
    Ai Zheng; 2006 Jul; 25(7):798-804. PubMed ID: 16831267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies.
    Watanabe T; Shinohara N; Sazawa A; Harabayashi T; Ogiso Y; Koyanagi T; Takiguchi M; Hashimoto A; Kuzumaki N; Yamashita M; Tanaka M; Grossman HB; Benedict WF
    Cancer Gene Ther; 2000 Dec; 7(12):1575-80. PubMed ID: 11228536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors upregulate expression of the coxsackie adenovirus receptor (CAR) preferentially in bladder cancer cells.
    Sachs MD; Ramamurthy M; Poel Hv; Wickham TJ; Lamfers M; Gerritsen W; Chowdhury W; Li Y; Schoenberg MP; Rodriguez R
    Cancer Gene Ther; 2004 Jul; 11(7):477-86. PubMed ID: 15118762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo adenovirus-mediated p53 and p16 tumor suppressor therapy in ovarian cancer.
    Modesitt SC; Ramirez P; Zu Z; Bodurka-Bevers D; Gershenson D; Wolf JK
    Clin Cancer Res; 2001 Jun; 7(6):1765-72. PubMed ID: 11410518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of sodium butyrate on proliferation of human gastric cancer cells and expression of p16 gene].
    Shen WJ; Dai DQ; Teng Y; Liu J
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1192-6. PubMed ID: 18844115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adenovirus p16(INK4A) gene therapy for laryngeal squamous cell carcinoma].
    Liu SX; Tang SQ; Liang CY
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2003 Feb; 38(1):35-8. PubMed ID: 12778765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination of adenovirus p16(INK4A) gene therapy and ionizing radiation for laryngeal squamous cell carcinoma].
    Fu YJ; Liu SX; Xian JM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Mar; 35(2):209-11. PubMed ID: 15071918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.